Literature DB >> 21115956

Neuroanatomic basis of amnestic MCI differs in patients with and without Parkinson disease.

J E Lee1, H-J Park, S K Song, Y H Sohn, J D Lee, P H Lee.   

Abstract

OBJECTIVE: To explore the neuroanatomic basis of amnestic mild cognitive impairment (aMCI) in patients with Parkinson disease (PD; aMCI-PD(+)) and without PD (aMCI-PD(-)).
METHODS: A total of 119 patients with aMCI (aMCI-PD(-), n = 78, and aMCI-PD(+), n = 41) underwent T1-weighted MRI, and the image data were analyzed using voxel-based morphometry.
RESULTS: No significant differences in demographic characteristics or general cognition were found between patients with aMCI-PD(-) and aMCI-PD(+). Comparisons of neuropsychological tests between groups revealed that patients with aMCI-PD(-) had lower scores in delayed verbal and visual recognition memory, whereas visuospatial dysfunction was more severe in patients with aMCI-PD(+). Gray matter (GM) density in the right temporal and posterior cingular cortices was significantly lower in the aMCI-PD(-) group compared with controls. In contrast, GM density in the aMCI-PD(+) group was significantly lower in the precuneus and left prefrontal and primary motor areas relative to controls. A direct comparison between groups showed that decreased GM density in aMCI-PD(-) relative to aMCI-PD(+) was localized in the right temporal and anterior prefrontal areas, whereas decreased GM density in aMCI-PD(+) relative to aMCI-PD(-) was involved in the bilateral precuneus, left primary motor, and right parietal areas. Memory decline was correlated with temporal area atrophy in aMCI-PD(-) and with posterior cingulate cortex atrophy in aMCI-PD(+).
CONCLUSIONS: Our data suggest that different neuroanatomic systems underlie memory dysfunction in patients with aMCI-PD(-) and aMCI-PD(+).

Entities:  

Mesh:

Year:  2010        PMID: 21115956     DOI: 10.1212/WNL.0b013e3181ff96bf

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

Review 1.  Mild cognitive impairment in Parkinson's disease.

Authors:  J G Goldman; I Litvan
Journal:  Minerva Med       Date:  2011-12       Impact factor: 4.806

2.  Clinical differences among mild cognitive impairment subtypes in Parkinson's disease.

Authors:  Jennifer G Goldman; Holly Weis; Glenn Stebbins; Bryan Bernard; Christopher G Goetz
Journal:  Mov Disord       Date:  2012-07-06       Impact factor: 10.338

Review 3.  Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease.

Authors:  Jennifer G Goldman; Neelum T Aggarwal; Cynthia D Schroeder
Journal:  Neurodegener Dis Manag       Date:  2015-10-30

4.  Neurocognitive and atrophic patterns in Parkinson's disease based on subjective memory complaints.

Authors:  Jin Yong Hong; Ji Eun Lee; Young H Sohn; Phil Hyu Lee
Journal:  J Neurol       Date:  2012-08       Impact factor: 4.849

5.  Cognitive status correlates with white matter alteration in Parkinson's disease.

Authors:  Takaaki Hattori; Satoshi Orimo; Shigeki Aoki; Kenji Ito; Osamu Abe; Atsushi Amano; Ryo Sato; Kasumi Sakai; Hidehiro Mizusawa
Journal:  Hum Brain Mapp       Date:  2011-04-14       Impact factor: 5.038

6.  The pattern of cortical atrophy in Parkinson's disease with mild cognitive impairment according to the timing of cognitive dysfunction.

Authors:  Ji E Lee; Kyoo H Cho; Myonghwan Kim; Young H Sohn; Phil Hyu Lee
Journal:  J Neurol       Date:  2011-08-05       Impact factor: 4.849

7.  Validation of a self-administered computerized system to detect cognitive impairment in older adults.

Authors:  Samuel D Brinkman; Robert J Reese; Larry A Norsworthy; Donna K Dellaria; Jacob W Kinkade; Jared Benge; Kimberly Brown; Anna Ratka; James W Simpkins
Journal:  J Appl Gerontol       Date:  2012-09-18

8.  Neurodegeneration across stages of cognitive decline in Parkinson disease.

Authors:  Daniel Weintraub; Jimit Doshi; Deepthi Koka; Christos Davatzikos; Andrew D Siderowf; John E Duda; David A Wolk; Paul J Moberg; Sharon X Xie; Christopher M Clark
Journal:  Arch Neurol       Date:  2011-12

9.  Initial cognitive decline is associated with cortical thinning in early Parkinson disease.

Authors:  Joana B Pereira; Per Svenningsson; Daniel Weintraub; Kolbjørn Brønnick; Alexander Lebedev; Eric Westman; Dag Aarsland
Journal:  Neurology       Date:  2014-05-07       Impact factor: 9.910

Review 10.  Mild cognitive impairment in Parkinson's disease.

Authors:  Amos D Korczyn
Journal:  J Neural Transm (Vienna)       Date:  2013-03-19       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.